Serum Thrombospondin-1 Is Altered in Patients with Hemorrhagic Fever with Renal Syndrome

Journal of Medical Virology

Volumn 80, Issue 10, 2008, Pages 1799-1803

  Liu, Zhengwen ^a   Zhao, Qianzi ^a   Han, Qunying ^a   Gao, Maicang ^a   Zhang, Ni ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Hantaan virus; Hemorrhagic fever with renal syndrome; Thrombospondin 1

Indexed keywords

THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEBRILE BONE MARROW APLASIA; HANTAVIRUS; HUMAN; HYPOTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENESIS; VIRUS HEMORRHAGIC FEVER;

ADULT; CHINA; FEMALE; FEVER; HANTAAN VIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; THROMBOSPONDIN 1;

HANTAAN VIRUS;

EID: 50849137874     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21270     Document Type: Article

References (37)

1. Bonnefoy A, Daenens K, Feys HB, De Vos R, Vandervoort P, Vermylen J, Lawler J, Hoylaerts MF. 2006. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood 107:955-964.
2. Chen HX, Qiu FX, Dong BJ, Ji SZ, Li YT, Wang Y, Wang HM, Zuo GF, Tao XX, Gao SY. 1986. Epidemiological studies on hemorrhagic fever with renal syndrome in China. J Infect Dis 154:394-398.
3. Cosgriff TM. 1991. Mechanisms of disease in Hantavirus infection: Pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 13:97-107.
4. Dameron KM, Volpert OV, Tainsky MA, Bouck N. 1994. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582-1584.
5. DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM, Polverini PJ. 1996. Thrombospondin 1 synthesis and function in wound repair. Am J Pathol 148:1851-1860.
6. Doyen V, Rubio M, Braun D, Nakajima T, Abe J, Saito H, Delespesse G, Sarfati M. 2003. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med 198:1277-1283.
7. Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML. 2005. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 111:2935-2942.
8. Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. 1999. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 73:3951-3959.
9. Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER. 2002. Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch Virol 147:1913-1931.
10. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER. 2002. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci USA 99:13837-13842.
11. Grimbert P, Bouguermouh S, Baba N, Nakajima T, Allakhverdi Z, Braun D, Saito H, Rubio M, Delespesse G, Sarfati M. 2006. Thrombospondin/CD47 interaction: A pathway to generate regulatory T cells from human CD4+ CD25- T cells in response to inflammation. J Immunol 177:3534-3541.
12. Guo N, Krutzsch HC, Inman JK, Roberts DD. 1997. Thrombospondin 1 and type 1 repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 57:1735-1742.
13. Hardestam J, Klingström J, Mattsson K, Lundkvist A. 2005. HFRS causing hantaviruses do not induce apoptosis in confluent Vero E6 and A-549 cells. J Med Virol 76:234-240.
14. Hugo C, Shankland S, Pichler R, Couser WG, Johnson RJ. 1998. Thrombospondin 1, a TGFβ activating protein, precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease. Kidney Int 53:302-311.
15. Iruela-Arispe ML, Bornstein P, Sage H. 1991. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88:5026-5030.
16. Lawler JW, Slayter HS, Coligan JE. 1978. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 253:8609-8616.
17. Lee HW. 1982. Hemorrhagic fever with renal syndrome (HFRS). Scand J Infect Dis 36:S82-S85.
18. Leung LL. 1984. Role of thrombospondin in platelet aggregation. J Clin Invest 74:1764-1772.
19. Liang M, Li D, Xiao SY, Hang C, Rossi CA, Schmaljohn CS. 1994. Antigenic and molecular characterization of hantavirus isolates from China. Virus Res 31:219-233.
20. Liu Z, Gao M, Han Q, Fang J, Zhao Q, Zhang N. 2008. Intensity of platelet beta (3) integrin in patients with hemorrhagic fever with renal syndrome and its correlation with disease severity. Viral Immunol 21:255-261.
21. Majack RA, Cook SC, Bornstein P. 1986. Control of smooth muscle cell growth by components of the extracellular matrix: Autocrine role for thrombospondin. Proc Natl Acad Sci USA 83:9050-9054.
22. McGregor B, Colon S, Mutin M, Chignier E, Zech P, McGregor J. 1994. Thrombospondin in human glomerulopathies: A marker of inflammation and early fibrosis. Am J Pathol 144:1281-1287.
23. Ministry of Health, PR China. 1988. Prevention and Treatment Strategy of HFRS. Zhonghua Chuanranbing Zazhi (Chin J Infect Dis) 6:188-192 (in Chinese).
24. Morandi V, Fauvel-Lafeve F, Legrand C, Legrand YJ. 1993. Role of thrombospondin in the adhesion of human endothelial cells in primary culture. In Vitro Cell Dev Biol Anim 29A:585-591.
25. Narizhneva NV, Razorenova OV, Podrez EA, Chen J, Chandrasekharan UM, DiCorleto PE, Plow EF, Topol EJ, Byzova TV. 2005. Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J 19:1158-1160.
26. Nathan FE, Hernandez E, Dunton CJ, Treat J, Switalska HI, Joseph RR, Tuszynski GP. 1994. Plasma thrombospondin levels in patients with gynecologic malignancies. Cancer 73:2853-2858.
27. Patel MK, Lymn JS, Clunn GF, Hughes AD. 1997. Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:2107-2114.
28. Rasche FM, Uhel B, Krüger DH, Karges W, Czock D, Hampl W, Keller F, Meisel H, von Müller L. 2004. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis 10:1420-1425.
29. Raugi GJ, Mullen JS, Bark DH, Okada T, Mayberg MR. 1990. Thrombospondin deposition in rat carotid artery injury. Am J Pathol 137:179-185.
30. Schmaljohn C, Hjelle B. 1997. Hantaviruses: A global disease problem. Emerg Infect Dis 3:95-104.
31. Takala A, Lähdevirta J, Jansson SE, Vapalahti O, Orpana A, Karonen SL, Repo H. 2000. Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury. J Infect Dis 181:1964-1970.
32. Taraboletti G, Roberts D, Liotta LA, Giavazzi R. 1990. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor. J Cell Biol 111:765-772.
33. Thakar CV, Zahedi K, Revelo MP, Wang Z, Burnham CE, Barone S, Bevans S, Lentsch AB, Rabb H, Soleimani M. 2005. Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest 115:3451-3459.
34. Tsai TF. 1987. Hemorrhagic fever with renal syndrome: Clinical aspects. Lab Anim Sci 37:419-427.
35. Tuszynski GP, Smith M, Rothman VL, Capuzzi DM, Joseph RR, Katz J, Besa EC, Treat J, Switalska HI. 1992. Thrombospondin levels in patients with malignancy. Thromb Haemost 67:607-611.
36. Yabkowitz R, Mansfield PJ, Ryan US, Suchard SJ. 1993. Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells. J Cell Physiol 157:24-32.
37. Yamashita Y, Kurohiji T, Tuszynski GP, Sakai T, Shirakusa T. 1998. Plasma thrombospondin levels in patients with colorectal carcinoma. Cancer 83:2043-2045.